Deka Biosciences is an innovative biotechnology company focused on developing targeted cytokine therapies for cancer and inflammatory diseases
Deka Biosciences is an innovative biotechnology company focused on developing targeted cytokine therapies for cancer and inflammatory diseases. Their platform, Diakine™, utilizes paired cytokines and advanced targeting systems to enhance immune response and reduce toxicity. The company emphasizes personalized medicine, leveraging genetic and biomarker insights to tailor treatments.